Andrew Johnson is CTO for AIMed with responsibility for database management, web development along with client management. A highly experienced publishing executive with a passion for technology.
Londhe VY and Bhasin B. Artificial Intelligence and its Potential in Oncology. Drug Discovery Today
2019; 24(1): 228-232.
Abstract
The two main branches associated with Artificial Intelligence (AI) in medicine are virtual and physical. The virtual component includes machine learning (ML) and algorithms, whereas physical AI includes medical devices and robots for delivering care. AI is used successfully in tumour segmentation, histopathological diagnosis, tracking tumour development, and prognosis prediction. CURATE.AI, developed at the National University of Singapore, is a platform that automatically decides the optimum dose of drugs for a durable response, allowing the patient to resume a completely normal life. With the involvement of technology multinationals, such as Google and Microsoft, in AI and healthcare in association with leading healthcare companies, the future of AI in healthcare looks very promising.
The full list of the top 100 articles on artificial intelligence and artificial intelligence in medicine are published here:
Intelligence- Based Medicine
Artificial Intelligence and Human Cognition in Clinical Medicine and Healthcare.
Anthony Chang, MD, MBA, MPH, MS
Leave A Comment
You must be logged in to post a comment.